CD44 and neoplasm: Researchers showed that breast cancer and glioblastoma are made up of a heterogeneous population of tumor cells, but only a certain population of cells (CD44+CD24−/low for breast cancer and CD133+ for glioblastoma) formed tumors that could be serially passaged and had the ability to reconstitute the original tumor morphology [17].